In 2013, the Drug Supply Chain Security Act (DSCSA) was passed into law to help monitor the distribution of prescription drugs in the US. The act outlines the steps that need to be taken to [...]
According to industry experts, the biosimilars market is set to take off in the US over the coming years. While Europe has been making biosimilar drugs available to patients for over a decade, with 27 [...]
Want to lower rising drug prices? Well, according to US Senators Bernie Sanders, Cory Booker, and Bob Casey, one way to go about doing this would be to allow the importation of lower-cost medications from countries [...]
Recognizing the detrimental effect rising drug prices is having on cancer patients, The American Society of Clinical Oncology (ASCO) recently released a position statement which aims to contribute to the national dialogue on the rising cost of [...]
On Thursday of last week, the US Senate passed a bill intended to improve treatment access for the country’s sickest patients. The Trickett Wendler Right to Try Act of 2017 passed by unanimous consent and [...]
Immunotherapy has become a hot topic in the oncology space over the past decade. For many cancer patients, the traditional treatment options, like chemotherapy, radiation therapy, or targeted therapies like Gleevec or Herceptin, are ineffective [...]
In America today, patients are paying more than double what patients in other nations are paying for the same prescription medications. The Trump administration has been working on an executive order that should tackle this [...]